223 related articles for article (PubMed ID: 19888323)
1. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants.
Folkersen L; Kyriakou T; Goel A; Peden J; Mälarstig A; Paulsson-Berne G; Hamsten A; Hugh Watkins ; Franco-Cereceda A; Gabrielsen A; Eriksson P;
PLoS One; 2009 Nov; 4(11):e7677. PubMed ID: 19888323
[TBL] [Abstract][Full Text] [Related]
2. Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease.
Zhuang J; Peng W; Li H; Wang W; Wei Y; Li W; Xu Y
PLoS One; 2012; 7(10):e47193. PubMed ID: 23091611
[TBL] [Abstract][Full Text] [Related]
3. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
4. Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study.
Johnson AD; Hwang SJ; Voorman A; Morrison A; Peloso GM; Hsu YH; Thanassoulis G; Newton-Cheh C; Rogers IS; Hoffmann U; Freedman JE; Fox CS; Psaty BM; Boerwinkle E; Cupples LA; O'Donnell CJ
Circulation; 2013 Feb; 127(7):799-810. PubMed ID: 23315372
[TBL] [Abstract][Full Text] [Related]
5. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.
Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S
Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
[TBL] [Abstract][Full Text] [Related]
7. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
[TBL] [Abstract][Full Text] [Related]
8. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
[TBL] [Abstract][Full Text] [Related]
9. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.
Holdt LM; Beutner F; Scholz M; Gielen S; Gäbel G; Bergert H; Schuler G; Thiery J; Teupser D
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):620-7. PubMed ID: 20056914
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.
Jarinova O; Stewart AF; Roberts R; Wells G; Lau P; Naing T; Buerki C; McLean BW; Cook RC; Parker JS; McPherson R
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1671-7. PubMed ID: 19592466
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.
Cunnington MS; Santibanez Koref M; Mayosi BM; Burn J; Keavney B
PLoS Genet; 2010 Apr; 6(4):e1000899. PubMed ID: 20386740
[TBL] [Abstract][Full Text] [Related]
12. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.
Harismendy O; Notani D; Song X; Rahim NG; Tanasa B; Heintzman N; Ren B; Fu XD; Topol EJ; Rosenfeld MG; Frazer KA
Nature; 2011 Feb; 470(7333):264-8. PubMed ID: 21307941
[TBL] [Abstract][Full Text] [Related]
13. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?
Hannou SA; Wouters K; Paumelle R; Staels B
Trends Endocrinol Metab; 2015 Apr; 26(4):176-84. PubMed ID: 25744911
[TBL] [Abstract][Full Text] [Related]
14. The chromosome 9p21.3 coronary heart disease risk allele is associated with altered gene expression in normal heart and vascular tissues.
Pilbrow AP; Folkersen L; Pearson JF; Brown CM; McNoe L; Wang NM; Sweet WE; Tang WH; Black MA; Troughton RW; Richards AM; Franco-Cereceda A; Gabrielsen A; Eriksson P; Moravec CS; Cameron VA
PLoS One; 2012; 7(6):e39574. PubMed ID: 22768093
[TBL] [Abstract][Full Text] [Related]
15. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis.
Liu Y; Sanoff HK; Cho H; Burd CE; Torrice C; Mohlke KL; Ibrahim JG; Thomas NE; Sharpless NE
PLoS One; 2009; 4(4):e5027. PubMed ID: 19343170
[TBL] [Abstract][Full Text] [Related]
16. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.
Burd CE; Jeck WR; Liu Y; Sanoff HK; Wang Z; Sharpless NE
PLoS Genet; 2010 Dec; 6(12):e1001233. PubMed ID: 21151960
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of the 9p21.3 CAD risk locus in Asian Indians.
Shanker J; Arvind P; Jambunathan S; Nair J; Kakkar V
Thromb Haemost; 2014 May; 111(5):960-9. PubMed ID: 24452806
[TBL] [Abstract][Full Text] [Related]
18. Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus.
Cunnington MS; Keavney B
Curr Atheroscler Rep; 2011 Jun; 13(3):193-201. PubMed ID: 21487702
[TBL] [Abstract][Full Text] [Related]
19.
Kong Y; Sharma RB; Ly S; Stamateris RE; Jesdale WM; Alonso LC
Diabetes; 2018 May; 67(5):872-884. PubMed ID: 29432124
[TBL] [Abstract][Full Text] [Related]
20. ANRIL: molecular mechanisms and implications in human health.
Congrains A; Kamide K; Ohishi M; Rakugi H
Int J Mol Sci; 2013 Jan; 14(1):1278-92. PubMed ID: 23306151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
